RE:RE:RE:RE:No one wants to deal with Gilles…."Wonder why no one is interested in Ceapro.....I guess it's because the industry players don't get it..."
Gilles said Symrise likes what CZO is doing and gave the example of a second-generation Aveeno with CoQ10. As the President and CEO of Roche Canada for 22 years it is hard to find a bigger name in Canadian pharma than Ronnie Miller who has been called an icon in the Canadian pharma. He joined CZO's Board of Directors and then became Chairman. The Canadian government has continued to be supportive with funding. Dr. Li is world renound. Dr. Ask is now a leading scientist wi Novartis and has expressed his excitement. The key is not to enter a deal too early and thereby give too much of the economic upside up. Gilles said he does not want a Mickey Mouse deal and has continued to advance the technlogy in terms of use-cases and towards commercialization. Once the current 5-10X scale-up is complete CZO should be able to secure stronger terms as the technology will be commercial. Data packages for use-cases are also being advanced.